2023 Rheumatology Year in Review (1.12.2024)

Join The Discussion

Jagannath chandrashekaran

| Jan 16, 2024 6:52 am

Permalink

Excellent and exciting times for immunology sector. Its challenging with epidemic proportion of autoimmune conditions encountered daily in clinical practice. We need systematic safe approach to use of new medication biologics and JAK inhibitors with age old medication in hand. We need to inculcate way to reduce the autoimmune trigger factors. We need continuous new updates to keep pace with current trends. Wellcome 2024.

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.